Articles tagged with Antibiotics
A recent study published in NEJM Evidence found that azithromycin use during severe RSV bronchiolitis does not prevent subsequent wheezing episodes and may even increase the risk. The study recommends against antibiotics during acute RSV bronchiolitis due to its lack of effect on the acute illness.
A new study has found that azithromycin does not prevent future recurrent wheezing among infants hospitalized with RSV. The antibiotic was tested in a large clinical trial involving 200 infants, and results showed that it may actually increase the risk of wheezing.
Researchers at MIT have synthesized himastatin, a natural compound with antimicrobial properties. The team discovered that the compound kills bacteria by disrupting their cell membranes.
Researchers at the University of Texas at Austin found a new approach to impairing antibiotic resistance in deadly bacteria by inhibiting the protein DsbA. This method could potentially restore the effectiveness of existing antibiotics, addressing a global health crisis responsible for millions of deaths annually.
A recent study has shed light on the protein structure that helps bacteria pump toxic molecules out of their cells, contributing to drug resistance. The researchers found that as a pH change occurs, the protein's channel opens and closes in a specific way, allowing the transport of toxic compounds.
A recent global study found that more than a quarter of the world's rivers had pharmaceutical concentrations at potentially toxic levels. The study, which included data from over 258 rivers across seven continents, also revealed concurrent contamination by multiple classes of pharmaceuticals.
Researchers discovered how a single mutation in an enzyme enables bacteria to evade antibiotics by using mirrored structures. This finding has implications for developing more resilient inhibitors and proactive drug designs.
SMART researchers identified a novel phage lysin, Abp013, with promising antimicrobial ability against Acinetobacter baumannii and Klebsiella pneumoniae. The study demonstrated Abp013's ability to effectively target complex bacterial environments and could advance treatment methods for multidrug-resistant Gram-negative pathogens.
Researchers found that streptomycin, a widely used antibiotic in U.S. agriculture, impairs bumblebee behavior, including reduced foraging efficiency and slowed cognition. The study aims to understand the potential impacts on pollinators of antibiotic use in agriculture.
A Swedish registry study found no increase in endocarditis cases among high-risk individuals since the removal of prophylactic antibiotics in dentistry. The study monitored over 76,000 high-risk individuals and 396,000 low-risk individuals from 2008 to 2018.
A new study from the University of Missouri-Columbia recommends pretreating urological patients with antibiotics tailored to their local infection patterns. This approach may reduce postoperative infections in transurethral procedures, which affect up to 10% of patients annually.
A mathematical modeling study predicts that routine immunization with TCV could avert 46-74% of all typhoid fever cases in 73 countries. Vaccination is also expected to reduce the relative prevalence of antimicrobial-resistant typhoid by 16%, preventing millions of cases and deaths.
A team of scientists at the University of Würzburg has identified a previously unknown RNA sponge, OppX, that mimics a key regulator of bacterial membrane permeability. The discovery sheds light on how bacteria evade antibiotics and could lead to the development of new therapeutics.
Decision-making tools, including a double-sided document and video training, were ineffective in reducing antibiotic prescription rates for acute respiratory infections. Despite this, general practitioners' knowledge of relevant evidence increased significantly after the intervention.
Researchers at TTUHSC developed novel hydrophilic nanoparticles that target bacterial membranes, killing pathogens while sparing mammalian cells. The nanoantibiotics' size-dependent activity reveals a new blueprint for developing non-toxic and environmentally friendly antibiotics.
A new report estimates that antibiotic-resistant bacterial infections caused over 1.27 million deaths worldwide in 2019, with the greatest impact on lower respiratory and bloodstream infections. The study highlights the urgent need to combat antimicrobial resistance and provides immediate actions for policymakers to save lives.
Researchers developed a mathematical model that can predict resistance outcomes for various drug pairs. The model, called JDFE, characterizes mutations available to bacteria and allows for classification of drug pairs into those that facilitate or hinder multi-drug resistance.
Rice University researchers developed a microfluidic platform to analyze how infectious bacteria evolve resistance to antibiotics. The platform allows for controlled environments and fine-tuning of conditions, revealing previously unknown pathways to resistance.
A new study by Vanderbilt University Medical Center found that a five-day course of antibiotics is superior to a 10-day strategy for treating community-acquired pneumonia in children under 6. The trial showed similar response rates and lower antibiotic resistance genes in the shorter treatment group.
A CHOP study found that infants born via uncomplicated cesarean delivery have a low risk of early-onset sepsis and should not receive antibiotics at birth. The study's findings could help clinicians tailor antibiotic use in newborns, reducing complications and unnecessary treatment.
Researchers at Sanford Burnham Prebys have received a $3.6 million grant to study antibiotic resistance, employing an innovative approach known as the 'evolution machine.' This project aims to shed new light on how bacteria develop resistance and inform more precise antibiotic prescribing practices.
A study published in Nature found that a type of MRSA called mecC-MRSA originated in hedgehogs over 200 years ago, long before the clinical use of antibiotics. The researchers believe that the bacteria evolved as an adaptation to living on the skin of hedgehogs with a fungus that produces its own antibiotics.
Researchers developed a promising alternative to traditional wet-chemistry methods using plasma-enabled surface engineering. The technology can create contact-killing, antifouling, and drug-release surfaces, accelerating antimicrobial material development.
A new species of antibiotic-resistant bacteria, Enterococcus innesii, has been discovered by researchers at the John Innes Centre. The strain is resistant to vancomycin and may cause hospital-acquired infections.
A study found that 88% of ED patients with suspected septic olecranon bursitis who received empiric antibiotics without aspiration resolved without needing further treatment. Conservative management may be a reasonable approach for select patients, potentially streamlining care and reducing complications.
New research combines antibiotics and phage therapy to cure infections more effectively and reduce antibiotic use. The study found that bacteriostatic antibiotics trigger CRISPR-Cas adaptive immunity in bacteria, increasing the chances of treatment efficacy.
Researchers at the University of Copenhagen have discovered that resistant bacteria can hide resistance genes in inactive bacteria within biofilms, creating a reservoir of resistance that can be drawn upon when antibiotics are not present. This new understanding challenges the long-held assumption that resistant bacteria lose their res...
Researchers identified 'pre-resistance' signs in bacteria, predicting future resistance to antibiotics. This discovery allows doctors to select the best treatments for bacterial infections and paves the way for personalized genomic therapy.
A recent review article by Duke University Medical Center suggests that antibiotics can be an effective first-line therapy for uncomplicated appendicitis cases, treating up to 70% of cases. However, the definitive treatment option remains surgery, usually done laparoscopically, for severely inflamed appendices or high-risk patients.
Scientists have discovered a new potential treatment to reverse antibiotic resistance in bacteria causing sepsis, pneumonia, and urinary tract infections. The indole carboxylates class of enzyme blockers can stop MBL resistance enzymes from working, allowing antibiotics like carbapenems to effectively target bacteria.
Researchers found fecal transplants increase IL-25, reducing tissue inflammation and boosting immune system response to C. difficile infections. The transplants also promote beneficial microbial diversity, helping patients heal from life-threatening diarrhea.
Research at University of Basel discovered that certain areas in tissue allow bacteria to survive despite antibiotic therapy. Immune system plays a critical role in eradicating bacteria, and boosting defenses with immune therapy can lead to more effective clearance.
A new study reveals widespread prescribing of clarithromycin-based regimens for H. pylori infection, defying increasing resistance and suboptimal eradication rates. Talicia, a rifabutin-based therapy, offers an alternative with higher eradication rates and fewer concerns over resistance.
Researchers have mapped the atomic structure of amphotericin B, a powerful but toxic antifungal agent. The detailed structure reveals how the drug kills fungal cells by robbing them of sterol molecules, providing a roadmap for synthesizing less-toxic derivatives.
Research shows that common medicines have distinct effects on gut bacteria, with some having beneficial and others detrimental impacts. The study found associations between certain medications and changes to the gut microbiome, particularly with statins and gastric acid medication.
Researchers found that many medications, including antibiotics and cardiometabolic drugs, can significantly alter the human gut microbiome. The study revealed a complex relationship between drug dosage and microbiome impact, highlighting the need for personalized treatment strategies.
Researchers at USC developed a new peptide that stimulates the host's immune response to fight bacterial infections, offering an alternative to antibiotics. The peptide, MTD12813, is highly effective in clearing infections and modulates inflammation, reducing the risk of complications.
A new white paper shares practical strategies to inform stewardship efforts and ensure appropriate use of antibiotics, citing the public health crisis of antibiotic resistance leading to 23,000 preventable deaths each year. Implementation science principles can bridge the evidence-practice gap.
A new study led by Rice University engineers finds that microplastic pollution contributes to the spread of antibiotic-resistant genes. The researchers discovered that aging polystyrene breaks down into microplastics with high surface areas, trapping microbes and leaching chemicals that enhance gene transfer.
Researchers found that gut microbiome changes can reduce b-amyloid deposits in male mice, indicating a potential target for preventing and treating dementia. Daily fecal matter transplants restored the pre-antibiotic microbiome, suggesting microglia memory plays a role.
Scientists have studied how different drugs affect Pseudomonas aeruginosa, revealing what makes it resistant to antibiotics. A new experimental substance called CHIR-090 has shown promise in blocking the production of sugar-lipid compounds, a previously unexploited target for treatment.
A recent study found that antibiotic resistance rates for Helicobacter pylori are decreasing in European countries. The use of three antibiotics over 10-14 days resulted in success rates of over 90%. The researchers hope to reduce antibiotic consumption to prevent further resistance.
Researchers from the University of Manchester have discovered a new way to manipulate key assembly line enzymes in bacteria using CRISPR-cas9 gene editing. This approach could lead to the production of improved antibiotics with potentially improved properties, addressing the growing threat of antimicrobial resistance.
A study led by New York University researchers found that the FDA-approved hepatitis C treatment telaprevir can increase bacterial sensitivity to antibiotics and reduce antibiotic resistance. The antiviral blocks the function of essential proteins in bacteria, revealing an opportunity to repurpose the drug to use alongside antibiotics.
Researchers at the University of Texas at Dallas have developed a vaccine method against recurrent urinary tract infections (UTIs) using metal-organic frameworks. The new approach produces substantially enhanced antibody production and significantly higher survival rates in mice compared to standard vaccine preparation methods.
The European Union and European Economic Area saw a significant decline in antibiotic consumption in 2020, with a 18% decrease compared to 2019. This decline was largely attributed to the COVID-19 pandemic, which led to reduced primary care consultations for mild infections.
Researchers at Karolinska Institutet have discovered a new group of small antibacterial compounds that inhibit the formation of bacterial cell walls, showing promise against antibiotic-resistant strains. The molecules work by binding to lipid II, a crucial molecule for bacterial cell wall construction.
Researchers at Hebrew University of Jerusalem discover a 'disrupted' state in bacteria that resists current antibiotics, requiring new pharmacological agents to combat. The breakthrough model predicts bacterial population responses to treatments, offering avenues for better treatments against cancer cells.
A study by Anglia Ruskin University has identified potentially dangerous Pseudomonas bacteria in 21% of wild bird faeces collected from locations near the River Cam. The bacteria, which can be passed on to humans through cross-contamination, were resistant to multiple antibiotics.
Scientists at the University of Southampton have created nanoparticles that can target and kill deadly bacteria hiding in human cells. The breakthrough could lead to a new treatment method using injectable or inhalation-based antibiotic-laden capsules, potentially saving thousands of lives annually.
A rapid same-day test has been developed to identify secondary infections in COVID-19 patients on intensive care, allowing for targeted antibiotic treatment and reduced risk of antimicrobial resistance. The test uses nanopore sequencing technology to analyze bacterial and fungal pathogens present in patient samples.
A new study found that regular antibiotic treatment with penicillin significantly reduced the risk of underlying rheumatic heart disease progression in children and adolescents. Early screening was critical in preventing serious disease progression and death in young children.
A new study found that low-dose CT scans are as accurate as standard-dose scans in diagnosing appendicitis and differentiating between uncomplicated and complicated cases. This breakthrough could lead to reduced radiation exposure for young patients, improving treatment outcomes.
Research identifies way of using nanoparticles to target and disrupt bacterial cells, making them more susceptible to standard antibiotic treatments. Laboratory studies show a strong effect in killing a range of bacteria, including some linked to hospital-acquired infections.
A new study found that heat and antibiotics alone and in combination degrade soil microbe efficiency, resilience, and ability to trap carbon. This could diminish soils' resilience to future stress and exacerbate climate change effects.
Researchers at Penn discovered a new suite of antimicrobial peptides, hidden within the human genome, which showed promising natural antibiotic potential. The peptides displayed antimicrobial activity against various pathogens, including E. coli and staph infection-causing bacteria.
The need for new antibiotics is critical due to rising antibiotic resistance, which kills over 35,000 people annually in the US. Research by Harvard Medical School aims to develop better antibiotics by targeting essential bacterial proteins.
A new report highlights the alarming global impact of Group B streptococcus, which can lead to up to 150,000 infant deaths annually. Maternal vaccination is seen as a cost-effective solution to reduce this toll, with significant health benefits in all regions.
A study published in The Lancet Infectious Diseases found that temocillin was effective in treating febrile urinary tract infections with fewer resistant bacteria. Temocillin acts specifically against E. coli and other intestinal bacteria, reducing the risk of treatment failure.
A new study reveals that iboxamycin effectively fights both gram-negative and gram-positive drug-resistant bacteria in mouse models. The researchers discovered the molecular mechanism that allows this drug to overcome resistance, which is important for developing new antibiotics.